therapies

Industry

Blackstone Life Sciences and Anthos Therapeutics Announce Novartis has Completed the Acquisition of Anthos Therapeutics in a Deal Valued at up to $3.1B, with...

iatanews - April 5, 2025

Blackstone Life Sciences and Anthos Therapeutics, Inc., a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of cardiometabolic diseases, announced that Novartis...

Blackstone Life Sciences and Anthos Therapeutics Announce Agreement for Anthos to be Acquired by Novartis for up to $3.1 Billion

iatanews - February 12, 2025

Blackstone Life Sciences and Anthos Therapeutics, Inc. (Anthos or the company), a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of...